✦ LIBER ✦

PD-069 Quality-of-Life (COL) assessment in two docetaxel dose-schedulesas second-line treatment of advanced non small cell lung cancer (NSCLC): Spanish Lung Cancer Group (SLCG) Phase III trial

✍ Scribed by Camps, C.; Massuti, B.; Jiménez, A.; Maestu, I.; Garcia, R.; Isla, M.; González-Larriba, J.; Almenar, D.; Carrato, A.; Rosell, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-2 TWO second-line docetaxel dose-sched

✍ Camps, Carlos; Massuti, Bartomeu; Jimenez, Ana Maria; Batista, Noberto; Galan, A 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 188 KB

Phase III trial comparing paclitaxel pol

✍ Paz-Ares, L; Ross, H; O'Brien, M; Riviere, A; Gatzemeier, U; Von Pawel, J; Kauke 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 143 KB

O-1 A phase III trial comparing weekly a

✍ Schuette, Wolfgang; Nagel, Sylke; Lautenschlaeger, C.; Serke, Monika; Wollschlae 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Docetaxel (Taxotere) shows survival and

✍ Frances A Shepherd; Frank V Fossella; Thomas Lynch; Jean-Pierre Armand; James R 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 602 KB

Docetaxel (Taxotere) shows survival and

✍ Frances A. Shepherd; Frank V. Fossella; Thomas Lynch; Jean-Pierre Armand; James 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 602 KB

P-588 Biweekly docetaxel and vinorelbine

✍ Vázquez, S.; Villanueva, M.; Amenedo, M.; Firvida, J.; Lázaro, M.; Del Río, L.; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB